“…Our goal is to develop a transposon-based activation tagging system that overcomes these limitations. Activation tags designed around the Activator (Ac)/Dissociation (Ds) (Wilson et al, 1996;Schaffer et al, 1998;Fridborg et al, 1999;Suzuki et al, 2001;Fladung and Polak, 2012) and Enhancer/Suppressor (Marsch-Martínez, 2011) transposon systems engineered with constitutive promotors or enhancer sequences clearly demonstrate that modified transposons retain their mobility and also induce gene expression. These approaches have been used to clone a variety of genes including TINY (Wilson et al, 1996), LATE ELONGATED HYPOCOTYL (Schaffer et al, 1998), SHORT INTERNODES (Fridborg et al, 1999), high phenolic compound1-1 Dominant (Schneider et al, 2005), and a strictosidine synthase (Mathieu et al, 2009).…”